These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1378014)

  • 1. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
    J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD; Murray RJ; Edwards CF; Rickinson AB
    J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
    Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity.
    Makgoba MW; Sanders ME; Ginther Luce GE; Gugel EA; Dustin ML; Springer TA; Shaw S
    Eur J Immunol; 1988 Apr; 18(4):637-40. PubMed ID: 2896596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymphocyte function-associated antigen (LFA)-1 and CD2/LFA-3 pathways of antigen-independent human T cell adhesion.
    Shaw S; Luce GE
    J Immunol; 1987 Aug; 139(4):1037-45. PubMed ID: 3302041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    Khanna R; Burrows SR; Thomson SA; Moss DJ; Cresswell P; Poulsen LM; Cooper L
    J Immunol; 1997 Apr; 158(8):3619-25. PubMed ID: 9103423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions.
    Barbosa JA; Mentzer SJ; Kamarck ME; Hart J; Biro PA; Strominger JL; Burakoff SJ
    J Immunol; 1986 Apr; 136(8):3085-91. PubMed ID: 3514752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
    Gromkowski SH; Heagy W; Martz E
    J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S; Masucci MG; Szigeti R; Bishara A; Brautbar C; Klein G; Klein E
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
    Masucci MG; Klein E
    Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewing to the LFA-3 adhesion pathway by influenza infection of antigen-presenting cells.
    van Kemenade FJ; Kuijpers KC; de Waal-Malefijt R; van Lier RA; Miedema F
    Eur J Immunol; 1993 Mar; 23(3):635-9. PubMed ID: 7680612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.